Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Aging People with MS
NCT06463743Phase 2Recruiting
- Sponsor
- University at Buffalo
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in multiple sclerosis (MS), sponsored by University at Buffalo. Started Sep 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06463743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06463743.